Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr 8;27(4):519-530.
doi: 10.1016/j.chom.2020.03.014.

The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies

Lillian B Cohn  1 , Nicolas Chomont  2 , Steven G Deeks  3
Affiliations
Review

The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies

Lillian B Cohn et al. Cell Host Microbe. .

Abstract

Antiretroviral therapy (ART) inhibits HIV replication but is not curative. During ART, the integrated HIV genome persists indefinitely within CD4+ T cells and perhaps other cells. Here, we describe the mechanisms thought to contribute to its persistence during treatment and highlight findings from numerous recent studies describing the importance of cell proliferation in that process. Continued progress elucidating the biology will enhance our ability to develop effective curative interventions.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interests S.G.D. receives grant support from Gilead, Merck, and ViiV. He is a member of the scientific advisory boards for BryoLogyx and Enochian Biosciences and has consulted for AbbVie, Biotron, and Eli Lilly.

Figures

Figure 1.
Figure 1.. HIV-1 persistence through clonal proliferation.
Three independent mechanisms are thought to drive proliferation of latently infected cells. First, the viral integration site may provide a survival advantage allowing preferential proliferation of the infected clone. Second, homeostatic cytokines, such as IL-7, may signal latently infected cells to divide. Finally, latently infected CD4+ T cells with antigen specific T cell receptors may divide in response to recurrent antigen exposure.
Figure 2.
Figure 2.. Antigen driven viral persistence.
The presence of chronic viral infection (in blue) leads to specific activation of antigen responsive CD4+ T cells. These activated T cells are targets for primary HIV-1 infection. Upon initiation of antiretroviral therapy, the majority of productively infected cells die rapidly, leaving behind latently infected cells. During repeated exposure to chronic virus, the latently infected, antigen specific cells divide, and the clones wax and wane in response to antigen exposure. If therapy is ceased, chronic viral antigen can be presented to latently infected cells which may trigger HIV-1 transcription and virus production, resulting in viral rebound and latent reservoir reseeding.
Figure 3.
Figure 3.. Clinical strategies for eradication.
Strategies are divided into those which aim to reduce the size of the reservoir, control viral rebound, or silence the reservoir.
See this image and copyright information in PMC

References

    1. Abdel-Mohsen M, Kuri-Cervantes L, Grau-Exposito J, Spivak AM, Nell RA, Tomescu C, Vadrevu SK, Giron LB, Serra-Peinado C, Genesca M, et al. (2018). CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells. Sci Transl Med 10. - PMC - PubMed
    1. Abrahams MR, Joseph SB, Garrett N, Tyers L, Moeser M, Archin N, Council OD, Matten D, Zhou S, Doolabh D, et al. (2019). The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation. Sci Transl Med 11. - PMC - PubMed
    1. Banga R, Procopio FA, Noto A, Pollakis G, Cavassini M, Ohmiti K, Corpataux JM, de Leval L, Pantaleo G, and Perreau M (2016). PD-1 and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals. Nat Med. - PubMed
    1. Banga R, Procopio FA, Ruggiero A, Noto A, Ohmiti K, Cavassini M, Corpataux JM, Paxton WA, Pollakis G, and Perreau M (2018). Blood CXCR3(+) CD4 T Cells Are Enriched in Inducible Replication Competent HIV in Aviremic Antiretroviral Therapy-Treated Individuals. Front Immunol 9, 144. - PMC - PubMed
    1. Bar KJ, Sneller MC, Harrison LJ, Justement JS, Overton ET, Petrone ME, Salantes DB, Seamon CA, Scheinfeld B, Kwan RW, et al. (2016). Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption. N Engl J Med 375, 2037–2050. - PMC - PubMed

Publication types

MeSH terms